¼¼°èÀÇ ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¾àÁ¦ À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)
Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1529773
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,302,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,698,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,488,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÃÀå ±Ô¸ð¿Í µ¿Çâ

½ÉÀå ÀÌ½Ä Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 10¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024-2030³â¿¡ °ÉÃÄ CAGR 4.25%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉºÎÀü, °ü»óµ¿¸ÆÁúȯ, ½É±ÙÁõ µî ½ÉÇ÷°üÁúȯ(CVDs)ÀÇ ÀÌȯÀ² »ó½ÂÀÌ ÀÌ ¼ºÀåÀ» Å©°Ô µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, PCR ¿Â¶óÀο¡ µû¸£¸é CVD´Â ¼¼°èÀÇ ³²³à ¸ðµÎ ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î ³²¾Æ ÀÖ½À´Ï´Ù. 2023³â ÇöÀç ¼¼°è Àα¸´Â 80¾ï ¸íÀÌ¸ç ¾à 6¾ï 2,000¸¸ ¸íÀÌ ½ÉÀ塤¼øÈ¯±â ÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ¸Å³â ¼¼°è ¾à 6,000¸¸ ¸íÀÌ ½ÉÀ塤¼øÈ¯±â ÁúȯÀ» ¹ßº´Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ºñ´ëÇü ½É±ÙÁõ(HCM)ÀÇ À¯º´·ü Áõ°¡´Â ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ºñ´ëÇü ½É±ÙÁõÀº ¼¼°è¿¡¼­ °¡Àå ÈçÇÑ À¯Àü¼º ½É±ÙÁõÀ¸·Î °£Áֵ˴ϴÙ. Cleveland Clinic¿¡ µû¸£¸é HCMÀÇ À¯º´·üÀº ¼¼°è¿¡¼­ ¾à 500¸í Áß 1¸íÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ ÁúȯÀº ºÎÁ¤¸Æ, ½ÉºÎÀü, ½ÉÀå µ¹¿¬»ç¿Í °°Àº ´Ù¾çÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñ´ëÇü ½É±ÙÁõ°ú´Â º°µµ·Î, ´Ù¸¥ À¯Àü¼º ½É±ÙÁõµµ ½ÃÀå ¼ºÀå¿¡ È¿°úÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¿©±â¿¡´Â È®´ë ½É±ÙÁõ, ±¸¼ÓÇü ½É±ÙÁõ, ºÎÁ¤¸Æ¿ø¼º ¿ì½É½É±ÙÁõÀÌ Æ÷ÇԵ˴ϴÙ. È®´ëÇü ½É±ÙÁõÀº HCMº¸´Ù À¯º´·üÀÌ ³ô°í, ¾à 2,000-2,500¸í¿¡ 1¸íÀÌ ¾Î°í ÀÖ½À´Ï´Ù.

Àå±â Á¦°ø°ú À̽Ŀ¡ °üÇÑ ÀÇ½Ä Çâ»ó¿¡ ´ëÇÑ ´ëóÀÇ °íÁ¶¿¡ ÀÇÇØ »çÈÄÀÇ Àå±â Á¦°ø¿¡ µ¿ÀÇÇÏ´Â »ç¶÷ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù, Stephen Donnelly º¸°ÇºÎ Àå°üÀº ¾ÆÀÏ·£µå¿¡¼­ Àå±â Á¦°ø°ú ÀÌ½Ä ¼­ºñ½ºÀÇ ¹ßÀü¿¡ ÃÊÁ¡À» ¸ÂÃá '2023³â Àå±â Á¦°ø °è¹ß ÁÖ°£'À» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ Àå°üÀº ¿¬¼³ Áß Àü³â¿¡ 250°ÇÀÇ À̽ÄÀÌ ÀÌ·ç¾îÁö°í 2023³â 1ºÐ±â¿¡´Â 81°ÇÀÇ À̽ÄÀÌ ÀÌ·ç¾îÁö´Â µî Àå±âÁ¦°ø½Ã½ºÅÛÀÌ COVID-19ÀÇ ¿µÇâÀ¸·ÎºÎÅÍ È¸º¹µÇ¾î ´«ºÎ½Å ½ºÅ¸Æ®¸¦ ²÷Àº °ÍÀ» °­Á¶Çß½À´Ï´Ù. Àå°üÀº ÀÌ½Ä ¼¾ÅÍ, ICU Á÷¿ø, Àå±â Á¦°ø °£È£»ç °ü¸®ÀÚ, Àå±â Á¦°ø ¹× ÀÌ½Ä ¾ÆÀÏ·£µå µî ÀÌ °úÁ¤¿¡ °ü·ÃµÈ ¸ðµç »ç¶÷µé¿¡°Ô °¨»çÀÇ ¶æÀ» ³ªÅ¸³Â½À´Ï´Ù. À̷νá À̽Ŀ¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ±âÁõÀÚ ½ÉÀå ºÎÁ·ÀÌ ¿ÏÈ­µÇ¾î ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â °øÅë ¿äÀÎÀÌÁö¸¸ ½ÃÀå ¼ºÀåÀ» Å©°Ô µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ½ÉÀå À̽ÄÀ» ÇÊ¿ä·Î ÇÒ ¼ö ÀÖ´Â ³ëÈ­¿Í °ü·ÃµÈ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀº Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. National Center for Health Statistics¿¡ µû¸£¸é 2020³â ¹Ì±¹¿¡¼­´Â 18¼¼ ÀÌ»óÀÇ ¼ºÀÎÀÇ 6.3%°¡ ½ÉÀ庴À¸·Î Áø´ÜµÇ¾ú½À´Ï´Ù.

2023³â Institute for Health Metrics and EvaluationÀÌ 1990-2022³â±îÁö ½ÉÇ÷°ü ÁúȯÀÇ ¼¼°è ºÎ´ã°ú À§ÇèÀ» Á¶»çÇÑ °á°ú Áß¿äÇÑ ÅëÂû·ÂÀÌ ¹àÇôÁ³½À´Ï´Ù.

Àå±â Á¦°ø·ü Çâ»ó, ÀÌ½Ä ÀÇ·á ¿¬±¸ Á¶¼º, Àå±â À̽Ŀ¡ °üÇÑ ±ÔÁ¦ ÇÁ·Î¼¼½ºÀÇ ÇÕ¸®È­¸¦ ¸ñÀûÀ¸·Î ÇÑ Á¤ºÎÀÇ ´ëóµµ ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀåÀÇ ÃßÁø¿¡ ÀÏ¿ª »ç°í ÀÖ½À´Ï´Ù. 2024³â 1¿ù ±¹Á¦½ÉÆóÀ̽ÄÇÐȸ(ISHLT)´Â ¿¬±¸È°µ¿À» Áö¿øÇϱâ À§ÇØ 40¸¸ ´Þ·¯ ÀÌ»óÀÇ ÀÚ±ÝÀ» ÇÒ´çÇß´Ù°í ¹àÇû½À´Ï´Ù. À̰ÍÀº ÁøÇàµÈ ½ÉÀå°ú Æó ÁúȯÀ» °¡Áø ȯÀÚÀÇ Ä¡·á¸¦ °­È­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¸Á¶±ÝÀº ISHLT Àç´ÜÀÇ ÀçÁ¤Àû Áö¿øÀ¸·Î °¡´ÉÇØÁ³½À´Ï´Ù. ÁÖ¸ñÇÒ¸¸ÇÑ °ÍÀº ÀÌ·¯ÇÑ º¸Á¶±ÝÀÌ 2023³â ISHLT º¸Á¶±Ý »çÀÌŬÀÇ µÎ ¹øÂ° ¶ó¿îµåÀÇ ÀÚ±ÝÀÌ µÇ´Â °ÍÀÔ´Ï´Ù.

½ÉÀå ÀÌ½Ä Ä¡·á ¼¼°è ½ÃÀå ¼¼ºÐÈ­ º¸°í¼­

ÀÌ º¸°í¼­´Â ¼¼°è, Áö¿ª ¹× ±¹°¡ ¼öÁØ¿¡¼­ ¼öÀÍ ¼ºÀåÀ» ¿¹ÃøÇϰí 2018-2030³â °¢ ÇÏÀ§ ºÎ¹®¿¡ ´ëÇÑ Ãֽо÷°è µ¿Ç⠺м®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ¿¬±¸¿¡¼­ Grand View Research, Inc.´Â ¼¼°èÀÇ ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀå º¸°í¼­¸¦ ¾à¹° À¯Çü, À¯Åë ä³Î ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀå : ¾àÁ¦ À¯Çü, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀå : À¯Åë ä³Î, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ½ÉÀå ÀÌ½Ä Ä¡·á ½ÃÀå :Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Market Size & Trends

The global heart transplantation therapeutics market size was estimated at USD 1.08 billion in 2023 and is anticipated to grow at a CAGR of 4.25% from 2024 to 2030. The rising incidence of cardiovascular diseases (CVDs), such as heart failure, coronary artery disease, and cardiomyopathy, majorly drives this growth. For instance, according to the PCR online, CVD continues to be the primary cause of death for both men and women worldwide. As of 2023, the global population is 8 billion, with approximately 620 million individuals living with heart and circulatory diseases. Each year, approximately 60 million people worldwide develop heart or circulatory diseases.

Furthermore, the increasing prevalence of hypertrophic cardiomyopathy (HCM)is one of the major factors contributing to the growth of the market for heart transplantation therapeutics. It is considered the most common inherited cardiomyopathy worldwide. As per the Cleveland Clinic[, the prevalence of HCM is estimated to affect approximately 1 in 500 individuals worldwide. This condition can lead to various complications, including arrhythmias, heart failure, and sudden cardiac death.Apart from hypertrophic cardiomyopathy, other genetic types of cardiomyopathies impact the market growth effectively. These include dilated cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Dilated cardiomyopathy is more prevalent than HCM, affecting about 1 in 2,000 to 2,500 individuals.

The growing efforts to raise awareness about organ donation and transplantation have led to more individuals consenting to donate their organs after death. For instance, in May 2023, the Minister for Health, Stephen Donnelly, launched Organ Donor Awareness Week 2023, focusing on the progress made in organ donation and transplantation services in Ireland. In his speech, he highlighted the system's recovery from the impact of COVID-19, with 250 transplants performed in the previous year and a remarkable start to 2023 with 81 transplants in the first quarter. The Minister expressed gratitude to all involved in the process, including transplant centers, ICU staff, organ donor nurse managers, and Organ Donation and Transplant Ireland. This has helped alleviate the shortage of donor hearts available for transplantation, thereby supporting the growth of the heart transplantation therapeutics market.

Moreover, the rising geriatric population worldwide is a common factor but significantly boosts market growth. The prevalence of age-related cardiovascular conditions that may necessitate heart transplantation is on the rise. Older individuals are more likely to develop heart failure or other cardiac issues that could benefit from heart transplant therapy, thereby driving the market growth.According to the National Center for Health Statistics, in 2020, 6.3% of adults aged 18 years and over had been diagnosed with heart disease in the U.S. This estimate is based on household interviews of a sample of the civilian, noninstitutionalized U.S. population.

In 2023, findings from the Institute for Health Metrics and Evaluation study on the global burden of cardiovascular diseases and risks for 1990-2022 revealed significant insights.

Government initiatives aimed at improving organ donation rates, funding research in transplant medicine, and streamlining regulatory processes for organ transplantation have also played a role in driving the heart transplantation therapeutics market forward. These supportive measures create a conducive environment for advancements in this field.In January 2024, the International Society for Heart and Lung Transplantation (ISHLT) disclosed that it has allocated over USD 400,000 in funding to support research endeavors. It aims to enhance the care of patients with advanced heart and lung diseases. These grants were made possible through the financial backing of the ISHLT Foundation. Notably, these grants represent the second round of funding for the 2023 ISHLT grant cycles.

Global Heart Transplantation Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global heart transplantation therapeutics market report based on drug type, distribution channel, and region:

U.S.

Canada

Mexico

UK

Germany

France

Italy

Spain

Norway

Sweden

Denmark

Japan

China

India

Australia

South Korea

Thailand

Brazil

Argentina

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Heart Transplantation Therapeutics Market Variables, Trends & Scope

Chapter 4. Heart Transplantation Therapeutics Market: Drug Type Estimates & Trend Analysis

Chapter 5. Heart Transplantation Therapeutics Market: Distribution Channel Estimates & Trend Analysis

Chapter 6. Heart Transplantation Therapeutics Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â